FRAMINGHAM HEART STUDY TASK ORDER 1 - BASE PERIOD

弗雷明汉心脏研究任务顺序 1 - 基础期

• 批准号: 10819409
• 负责人: VASAN RAMACHANDRAN
• 金额: $ 482.41万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2024-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10819409
• 关键词: Aging; Ancillary Study; Biological Specimen Banks; Clinical; Communities; Data; Disease; Disease Progression; Event; Framingham Heart Study; Functional disorder; Goals; Heart Diseases; Hematological Disease; Knowledge; Lung diseases; Participant; Research Personnel; Resources; Risk Factors; Sleep Disorders; base; clinical examination; clinical predictors; data repository; follow-up; health determinants; progression risk

This renewal is to continue the Framingham Heast Study (FHS) as a scientific resource for the research community to expand knowledge about the determinants of health and disease in heart, lung, blood, and sleep disorders. The overall goals of this acquisition are to (1) enhance statistical power to perform analyses of predictors of clinical events; (2) study the progression of risk factors with aging; and (3) identify new risk factors or interactions between risk factors that inform disease pathophysiology and/or disease progression.

这次更新是为了继续Frauptheast研究（FHS）作为研究界的科学资源，以扩大有关心脏，肺，血液和睡眠障碍的健康和疾病的决定因素的知识。此次收购的总体目标是：（1）增强统计功效，以分析临床事件的预测因子;（2）研究风险因素随年龄增长的进展;（3）识别新的风险因素或风险因素之间的相互作用，从而为疾病病理生理学和/或疾病进展提供信息。